Immuron Limited has announced a new research collaboration agreement with Monash University. The objective of this collaboration is to develop new therapeutic drug candidates targeting antimicrobial resistant pathogens. The research will focus on understanding the mechanisms that bacteria utilize to share and transfer their DNA, with the aim to develop broad-spectrum therapeutic drug products to address the threat of antimicrobial resistance.